Cheaper HIV treatment for children: a report in The Lancet
A new pricing agreement will bring the cost of treatment for children with HIV down from US$480 to less than $120.READ MORE
We are a Global
Paediatric Research Network
devoted to determining and implementing the best ways
to prevent, diagnose and treat diseases in children
Linking experts from
around the world
in an independent global collaboration that seeks to standardize
best practices across disease areas and populations
Sharing Values and Goals
such as flexibility, commitment and transparency
Researching the right drug
and the right dose
to generate the scientific data necessary to market drugs
at doses that are safe and effective for children
Understanding the
Immune Response
so as to harness the body's response
to HIV and antiretrovirals
Fighting
Antimicrobial Resistance
to ensure effective treatments are available
for common infections for generations to come
Paving the way for women,
children and their families
to make powerful informed decisions about their health
and healthcare and improve the quality of their lives
LATEST NEWS
First patient enrolled in PediCAP trial
We are proud to announce that on the 7th of December 2020, the PediCAP team at Makerere University at the China-Uganda Friendship Hospital Naguru (Kampala, Uganda) recruited the very first participant into the PediCAP clinical trial. Though the study experienced a delayed start due to the COVID-19 pandemic, the drive and commitment of the Ugandan…READ MORE
GET TO KNOW US
Through independent research into child health, Penta is one of the most prominent scientific organizations dedicated to children’s health.
We are an alliance of people united by a common purpose: to improve prevention, diagnosis and treatment of infection in children.
Our global independent scientific network brings together key stakeholders in paediatric infectious disease, including researchers, clinicians, regulatory bodies, the pharmaceutical industry and patients and their families, to develop and deliver world class research and training to drive contemporary understanding and practice related to infections in children.
We are involved in research projects globally that operate along the scientific priorities: HIV & viral infection, severe sepsis and antimicrobial resistance, infection in pregnancy and neglected or emerging childhood infections. We do not just carry out clinical trials, but cohort studies collaboration and pregnancy studies.
Our research embraces basic, pharmacological, clinical, social and population sciences.
Our operational model is based on networking, independence, transparency and commitment.
We continue to build on our existing partnerships and seek out potential new collaborations to further our work.
Keep up to date with the latest Penta news
CURRENT PENTA STUDIES AROUND THE WORLD
ALWAYS EXPANDING
The Penta ID Network continues to grow, bringing together patients and their care-givers worldwide to address a wide range of healthcare issues.
110
CLINICAL SITES
31
COUNTRIES
29
YEARS OF ACTIVITY
24
EU FUNDED PROJECTS
PARTNERSHIPS
